Everest Medicines Limited (HKG:1952)
48.98
+0.52 (1.07%)
Oct 31, 2025, 4:08 PM HKT
Everest Medicines Employees
Everest Medicines had 665 employees as of December 31, 2024. The number of employees increased by 233 or 53.94% compared to the previous year.
Employees
665
Change (1Y)
233
Growth (1Y)
53.94%
Revenue / Employee
1.29M HKD
Profits / Employee
-999.79K HKD
Market Cap
17.30B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 665 | 233 | 53.94% |
| Dec 31, 2023 | 432 | 67 | 18.36% |
| Dec 31, 2022 | 365 | -40 | -9.88% |
| Dec 31, 2021 | 405 | 256 | 171.81% |
| Dec 31, 2020 | 149 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sino Biopharmaceutical | 24,379 |
| CSPC Pharmaceutical Group | 21,400 |
| WuXi Biologics | 12,575 |
| BeOne Medicines AG | 11,000 |
| Hansoh Pharmaceutical Group Company | 8,989 |
| Innovent Biologics | 5,659 |
| JD Health International | 3,564 |
| Akeso | 3,035 |
Everest Medicines News
- 7 months ago - AI-powered Cancer Vaccine In The Works - Benzinga
- 1 year ago - Kezar Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update - Benzinga